NCT04462081 Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients Status COMPLETED Phase N/A
NCT04399538 Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis Status COMPLETED Phase PHASE2
NCT04389775 To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT04389593 Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference Status COMPLETED Phase N/A
NCT04342793 A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH Status COMPLETED Phase PHASE2
NCT04235205 Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease Status COMPLETED Phase PHASE2
NCT04216693 Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH) Status WITHDRAWN Phase PHASE2
NCT04210245 Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) Status COMPLETED Phase PHASE2
NCT04166773 A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE2
NCT04147195 Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) Status TERMINATED Phase PHASE2
NCT04137055 Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP0678, and the Effect of Food on ZSP0678 Pharmacokinetics Status COMPLETED Phase PHASE1
NCT04031729 Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease Status COMPLETED Phase PHASE1/PHASE2
NCT04012242 Innovative Liver Elasticity, Attenuation, and Dispersion Ultrasound Study Status UNKNOWN Phase N/A
NCT03987074 Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE2
NCT03970031 A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH Status UNKNOWN Phase PHASE3
NCT03725631 Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD Status UNKNOWN Phase NA